ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 34757 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 34757; 2) Community: the network communities that were significantly associated with the response to NSC 34757; 3) Molecule: the relationships between components within communities and NSC 34757; 4) MDR: the compounds that were significantly associated with the NSC 34757.

NSC Compound Enrichment Correlation
NSC 674498 Null 0.0395466756030208 0.24520879
NSC 716030 Null 0.0395466756030208 0.20191403
NSC 721041 Null 0.0395466756030208 0.23101298
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0396077140933374 0.049848229
NSC 278619 L-Arabinose, 2-amino-4-[(2-amino-1-oxopropyl)amino]-2,4-dideoxy-, monohydrochloride 0.0396077140933374 -0.018952093
NSC 610457 Camptothecin Derivative 0.0396077140933377 0.10392471
NSC 622070 Null 0.0396077140933377 0.27258219
NSC 645317 Sanguilutine pseudobase 0.0396077140933377 0.49864528
NSC 651774 Null 0.0396077140933377 0.33546339
NSC 674685 Null 0.0396077140933377 0.6429773
Total:60  Current:52    [First] [Prev] [Next] [Last]